Vanguard Portfolio Management
XERS icon

Vanguard Portfolio Management’s Xeris Biopharma Holdings XERS Stock Holding History

Vanguard Portfolio Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.8M Sell
2,626,208
-39,400
-1% -$252K ﹤0.01% 1980
2026
Q1 		$15.5M Buy
+2,665,608
New +$17.7M ﹤0.01% 1984

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Vanguard Portfolio Management's XERS Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Xeris Biopharma Holdings (XERS) stake by 1.5% in Q2 2026, selling an estimated $252K and leaving 2,626,208 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

Vanguard Portfolio Management first reported a position in XERS in Q1 2026 and has held it in 2 quarters since. 217 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Vanguard Portfolio Management held 2,626,208 shares of Xeris Biopharma Holdings worth $20.8M as of Q2 2026.
  • Vanguard Portfolio Management sold 39,400 Xeris Biopharma Holdings shares in Q2 2026, an estimated $252K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1980 holding.
  • Vanguard Portfolio Management first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • 217 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.